Information Journal Paper
APA:
Copy. (2020). Inhibition of SARS-CoV-2 infection (previously 2019-nCoV) by a highly potent pan-coronavirus fusion inhibitor targeting its spike protein that harbors a high capacity to mediate membrane fusion. bioRxiv, -(-), 0-0. SID. https://sid.ir/paper/685069/en
Vancouver:
Copy. Inhibition of SARS-CoV-2 infection (previously 2019-nCoV) by a highly potent pan-coronavirus fusion inhibitor targeting its spike protein that harbors a high capacity to mediate membrane fusion. bioRxiv[Internet]. 2020;-(-):0-0. Available from: https://sid.ir/paper/685069/en
IEEE:
Copy, “Inhibition of SARS-CoV-2 infection (previously 2019-nCoV) by a highly potent pan-coronavirus fusion inhibitor targeting its spike protein that harbors a high capacity to mediate membrane fusion,” bioRxiv, vol. -, no. -, pp. 0–0, 2020, [Online]. Available: https://sid.ir/paper/685069/en